Literature DB >> 34278682

Supporting cancer care clinicians to 'hold' their patients during and beyond the COVID-19 pandemic: a role for reflective ethics discussions.

Clare Delany1, Joanne Benhamu2, Rosalind McDougall3, Danielle Ko4, Hayley Jones5, Linda Mileshkin2, Geraldine Largey6, Alex Clinch2, Sarah Heynemann4.   

Abstract

The COVID-19 pandemic has placed an overwhelming burden on healthcare delivery globally. This paper examines how COVID-19 has affected cancer care clinicians' capacity to deliver cancer care in the Australian context. We use the lens of 'holding patients' (drawing from attachment theory, psychology and from Australian Indigenous knowledge) to conceptualise cancer clinicians' processes of care and therapeutic relationships with patients. These notions of 'holding' resonate with the deep responsibility cancer care clinicians feel towards their patients. They enrich ethical language beyond duties to benefit, avoid harm, respect patients' autonomy and provide just treatment. We consider the disruptive effects of COVID-19 on care delivery and on clinicians themselves. We then show how models of clinical ethics and other similar reflective discussion approaches are a relevant support mechanism to assist clinicians to process and make sense of COVID-19's disruptions to their professional ethical role of holding patients during and beyond the pandemic.
© 2021 Royal Australasian College of Physicians.

Entities:  

Keywords:  COVID-19; cancer care clinicians; clinical ethics; holding patients; moral distress

Year:  2021        PMID: 34278682     DOI: 10.1111/imj.15375

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  1 in total

Review 1.  Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic.

Authors:  Brenda Bogaert; Victoria Buisson; Zizis Kozlakidis; Pierre Saintigny
Journal:  Crit Rev Oncol Hematol       Date:  2022-03-23       Impact factor: 6.625

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.